Your browser doesn't support javascript.
loading
Anticoagulation in adults with congenital heart disease: The who, the when and the how?
Jensen, A S; Idorn, L; Nørager, B; Vejlstrup, N; Sondergaard, L.
Affiliation
  • Jensen AS; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, UK.
  • Idorn L; Department of Pediatrics, Section of Pediatric Cardiology, Rigshospitalet, Copenhagen, Denmark.
  • Nørager B; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
  • Vejlstrup N; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
  • Sondergaard L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Heart ; 101(6): 424-9, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25281599
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heart Defects, Congenital / Anticoagulants Type of study: Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2015 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heart Defects, Congenital / Anticoagulants Type of study: Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2015 Document type: Article Affiliation country: